Wednesday, June 30, 20218:00 - 9:00 pm CT
Moderator: Samuel B. Adams, MDFaculty: Selene G. Parekh, MD, MBA; H. Thomas Temple, MD; Sheldon S. Lin, MD; Daniel Guss, MD, MBA
Nonunions after attempted bony fusion procedures can be devastating for the patient and surgeon, and they burden the already cash-strapped US healthcare system. Many patients treated with arthrodesis procedures have comorbidities that preclude them from fusion. In this webinar, faculty will explore the role of orthobiologics in enhancing bone fusion and the characteristics of patients who might benefit from this treatment.
At the conclusion of this webinar, you will be able to:
Understand the classes and mechanism of action of orthobiologics available to enhance bone fusion
Identify patients who might benefit from the use of biologic enhancement for bone fusion
Understand the data and efficacy behind biologics